TY - JOUR
T1 - Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
AU - Bowman, Louise
AU - Hopewell, Jemma C
AU - Chen, Fang
AU - Wallendszus, Karl
AU - Stevens, William
AU - Collins, Rory
AU - Wiviott, Stephen D
AU - Cannon, Christopher P
AU - Braunwald, Eugene
AU - Sammons, Emily
AU - Landray, Martin J
AU - HPS3/TIMI55–REVEAL Collaborative Group
A2 - Schmidt, Erik Berg
A2 - Dinesen, Pia Thisted
A2 - Gammelmark, Anders
A2 - Rix, Thomas Andersen
A2 - Vadmann, Henrik
A2 - Andersen , Karen Petrea
A2 - Christensen, B.
A2 - Kobbelgaard, Lotte Hessing
A2 - Mikkelsen, Birgitte Charlotte
A2 - Pedersen, Mette Storgaard
A2 - Torp-Pedersen, Christian
PY - 2017/9/28
Y1 - 2017/9/28
KW - Aged
KW - Anticholesteremic Agents
KW - Atherosclerosis
KW - Cholesterol
KW - Cholesterol Ester Transfer Proteins
KW - Coronary Disease
KW - Double-Blind Method
KW - Drug Therapy, Combination
KW - Female
KW - Humans
KW - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW - Incidence
KW - Kaplan-Meier Estimate
KW - Male
KW - Medication Adherence
KW - Middle Aged
KW - Oxazolidinones
KW - Clinical Trial, Phase III
KW - Journal Article
KW - Multicenter Study
KW - Randomized Controlled Trial
KW - Research Support, Non-U.S. Gov't
U2 - 10.1056/NEJMoa1706444
DO - 10.1056/NEJMoa1706444
M3 - Journal article
C2 - 28847206
VL - 377
SP - 1217
EP - 1227
JO - The New England Journal of Medicine
JF - The New England Journal of Medicine
SN - 0028-4793
IS - 13
ER -